Imunovir: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) (add ref, links, cat, tidy, fix drug name) |
(Added ref) |
||
| Line 1: | Line 1: | ||
{{stub}} | {{stub}} | ||
'''Imunovir''' or '''inosine pranobex''' is an [[:Category:Immunostimulants|immunostimulant]]. In a pilot study of sixteen [[chronic fatigue syndrome]] patients it increased [[natural killer cell]] activity and resulted in a clinical improvement in 60% of patients.<ref>{{Cite book|url=https://books.google.com/books/about/Treatment_of_Chronic_Fatigue_Syndrome_in.html?id=gBekAgAAQBAJ|title=Treatment of Chronic Fatigue Syndrome in the Antiviral Revolution Era: What Does the Research Say?|last=Patarca-Montero|first=Roberto|date=|publisher=Routledge|year=2014|isbn=9781135416294|editor-link=|location=|pages=41-42|language=en|chapter=|quote=|author-link=Roberto Patarca-Montero|editor-last2=|editor-link2=}}</ref> | '''Imunovir''' or '''inosine pranobex''' is an [[:Category:Immunostimulants|immunostimulant]]. In a pilot study of sixteen [[chronic fatigue syndrome]] patients it increased [[natural killer cell]] activity and resulted in a clinical improvement in 60% of patients.<ref>{{Cite journal|last=Diaz-Mitoma|first=Francisco|last2=Turgonyi|first2=Eva|last3=Kumar|first3=Ashok|last4=Lim|first4=Wilfred|last5=Larocque|first5=Louise|last6=Hyde|first6=Byron M.|date=2003-01-01|title=Clinical Improvement in Chronic Fatigue Syndrome Is Associated with Enhanced Natural Killer Cell-Mediated Cytotoxicity: The Results of a Pilot Study with Isoprinosine®|url=https://doi.org/10.1300/J092v11n02_06|journal=Journal of Chronic Fatigue Syndrome|volume=11|issue=2|pages=71–95|doi=10.1300/J092v11n02_06|issn=1057-3321}}</ref><ref>{{Cite book|url=https://books.google.com/books/about/Treatment_of_Chronic_Fatigue_Syndrome_in.html?id=gBekAgAAQBAJ|title=Treatment of Chronic Fatigue Syndrome in the Antiviral Revolution Era: What Does the Research Say?|last=Patarca-Montero|first=Roberto|date=|publisher=Routledge|year=2014|isbn=9781135416294|editor-link=|location=|pages=41-42|language=en|chapter=|quote=|author-link=Roberto Patarca-Montero|editor-last2=|editor-link2=}}</ref> | ||
==References== | ==References== | ||
Revision as of 18:09, July 5, 2020
 | This article is a stub. |
Imunovir or inosine pranobex is an immunostimulant. In a pilot study of sixteen chronic fatigue syndrome patients it increased natural killer cell activity and resulted in a clinical improvement in 60% of patients.[1][2]
References[edit | edit source]
- ↑ Diaz-Mitoma, Francisco; Turgonyi, Eva; Kumar, Ashok; Lim, Wilfred; Larocque, Louise; Hyde, Byron M. (January 1, 2003). "Clinical Improvement in Chronic Fatigue Syndrome Is Associated with Enhanced Natural Killer Cell-Mediated Cytotoxicity: The Results of a Pilot Study with Isoprinosine®". Journal of Chronic Fatigue Syndrome. 11 (2): 71–95. doi:10.1300/J092v11n02_06. ISSN 1057-3321.
- ↑ Patarca-Montero, Roberto (2014). Treatment of Chronic Fatigue Syndrome in the Antiviral Revolution Era: What Does the Research Say?. Routledge. pp. 41–42. ISBN 9781135416294.
